摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-bis(3,4,5-trimethoxybenzoyl)ethane | 101394-53-0

中文名称
——
中文别名
——
英文名称
1,2-bis(3,4,5-trimethoxybenzoyl)ethane
英文别名
1,4-Bis(3,4,5-trimethoxyphenyl)butane-1,4-dione
1,2-bis(3,4,5-trimethoxybenzoyl)ethane化学式
CAS
101394-53-0
化学式
C22H26O8
mdl
——
分子量
418.444
InChiKey
WIHPXSZYTZBECI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    570.8±50.0 °C(Predicted)
  • 密度:
    1.170±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    30
  • 可旋转键数:
    11
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    89.5
  • 氢给体数:
    0
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,2-bis(3,4,5-trimethoxybenzoyl)ethane 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 以4.2 g的产率得到1,4-bis(3,4,5-trimethoxyphenyl)-1,4-butanediol
    参考文献:
    名称:
    四氢呋喃木脂素和类似物作为特定血小板活化因子拮抗剂的构象和活性。
    摘要:
    制备了3,4-二甲基-2,5-双(3,4-二甲氧基苯基)四氢呋喃的六个(外消旋或内消旋)异构体和四个相应的去甲基类似物,并将其检测为血小板活化因子(PAF)受体与兔结合的抑制剂血小板质膜。这些异构体的抑制作用是立体依赖性的,并随分子力学程序MM2确定的分子总体形状而变化。这组化合物中最有效的PAF拮抗剂是反式-2,5-双(3,4,5-三甲氧基苯基)四氢呋喃(L-652,731,14),IC50为0.02 microM。
    DOI:
    10.1021/jm00160a020
  • 作为产物:
    参考文献:
    名称:
    四氢呋喃木脂素和类似物作为特定血小板活化因子拮抗剂的构象和活性。
    摘要:
    制备了3,4-二甲基-2,5-双(3,4-二甲氧基苯基)四氢呋喃的六个(外消旋或内消旋)异构体和四个相应的去甲基类似物,并将其检测为血小板活化因子(PAF)受体与兔结合的抑制剂血小板质膜。这些异构体的抑制作用是立体依赖性的,并随分子力学程序MM2确定的分子总体形状而变化。这组化合物中最有效的PAF拮抗剂是反式-2,5-双(3,4,5-三甲氧基苯基)四氢呋喃(L-652,731,14),IC50为0.02 microM。
    DOI:
    10.1021/jm00160a020
点击查看最新优质反应信息

文献信息

  • 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antagonists
    申请人:Merck & Co., Inc.
    公开号:US04757084A1
    公开(公告)日:1988-07-12
    Analogs of 2,5-Diaryl tetrahydrothiophenes which were substituted or unsubstituted on 3,4-positions were prepared. These compounds are found to be leukotriene inhibitors and potent and specific PAF (Platelet Activating Factor) antagonists. They are therefore useful in the treatment of various diseases or disorders mediated by the leukotriene and/or PAF, for example, inflammation, cardiovascular disorder, asthma, lung edema, adult respiratory distress syndrome, pain, and aggregation of platelets.
    制备了在3,4位上取代或未取代的2,5-二芳基四氢噻吩类似物。这些化合物被发现是白三烯抑制剂和有效、特异的血小板活化因子(PAF)拮抗剂。因此,它们在治疗由白三烯和/或PAF介导的各种疾病或障碍中非常有用,例如炎症、心血管障碍、哮喘、肺水肿、成人呼吸窘迫综合征、疼痛和血小板聚集。
  • New 2,5-diaryl tetrahydrofurans and analogs thereof as paf antagonists
    申请人:Merck & Co., Inc.
    公开号:EP0322033A2
    公开(公告)日:1989-06-28
    A class of 2,5-diaryl tetrahydrofuran derivatives are PAF antagonists and are therefore useful in the treatment of various diseases including prevention of platelet aggregation, hypotension, inflammation, asthma, lung edema, adult respiratory distress syndrome, various shock syndromes, cardiovascular disorders and other related skeletal-muscular disorders.
    一类 2,5-二甲基四氢呋喃衍生物是 PAF 拮抗剂,因此可用于治疗各种疾病,包括预防血小板聚集、低血压、炎症、哮喘、肺水肿、成人呼吸窘迫综合征、各种休克综合征、心血管疾病和其他相关的骨骼肌肉疾病。
  • New 2,5-diaryl tetryhydrofurans and analogs thereof as paf antagonists
    申请人:Merck & Co., Inc.
    公开号:EP0199324B1
    公开(公告)日:1991-10-02
  • New 2,5-diaryl tetrahydrothiophenes and analogs thereof as paf-antagonists
    申请人:Merck & Co., Inc.
    公开号:EP0154887B1
    公开(公告)日:1989-01-25
  • Method and system for the generation of large double stranded DNA fragments
    申请人:Cerrina Francesco
    公开号:US20070196834A1
    公开(公告)日:2007-08-23
    Synthesis of long chain molecules such as DNA is carried out rapidly and efficiently to produce relatively large quantities of the desired product. The synthesis of an entire gene or multiple genes formed of many hundreds or thousands of base pairs can be accomplished rapidly and, if desired, in a fully automated process requiring minimal operator intervention, and in a matter of hours, a day or a few days rather than many days or weeks. Production of a desired gene or set of genes having a specified base pair sequence is initiated by analyzing the specified target sequence and determining an optimal set of subsequences of base pairs that can be assembled to form the desired final target sequence. The set of oligonucleotides are then synthesized utilizing automated oligonucleotide synthesis techniques. The synthesized oligonucleotides are subsequently selectively released from the substrate and used in a sequential assembly process.
查看更多